Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat in Advanced Small Cell Lung Cancer
NCT01222936Phase 2Completed
- Sponsor
- Southern Europe New Drug Organization
- Start
- May 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of panobinostat in Small Cell Lung Cancer (SCLC), sponsored by Southern Europe New Drug Organization. Started May 2008; status: completed.
02
Drugs
panobinostat
03
Conditions
Small Cell Lung Cancer (SCLC)
Beyond the preview
Go deeper on NCT01222936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01222936.